R. Townsend

1.1k total citations
21 papers, 472 citations indexed

About

R. Townsend is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Economics and Econometrics. According to data from OpenAlex, R. Townsend has authored 21 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 4 papers in Economics and Econometrics. Recurrent topics in R. Townsend's work include Diabetes Treatment and Management (7 papers), Diabetes Management and Research (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). R. Townsend is often cited by papers focused on Diabetes Treatment and Management (7 papers), Diabetes Management and Research (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). R. Townsend collaborates with scholars based in United Kingdom, France and United States. R. Townsend's co-authors include Phil McEwan, Klas Bergenheim, M. Charokopou, Gail Wygant, W. Ray Kim, Yong Yuan, Ian Wood, A H Barnett, Neil Hawkins and Sarah Goring and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Medicine & Science in Sports & Exercise and International Journal of Obesity.

In The Last Decade

R. Townsend

21 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Townsend United Kingdom	12	244	111	79	66	64	21	472
Chardpraorn Ngarmukos Thailand	14	266 1.1×	89 0.8×	79 1.0×	71 1.1×	70 1.1×	24	558
Louisa Y.F. Wong Hong Kong	12	332 1.4×	117 1.1×	298 3.8×	55 0.8×	99 1.5×	15	739
Ah Reum Khang South Korea	13	241 1.0×	84 0.8×	100 1.3×	131 2.0×	111 1.7×	36	484
Kyoung‐Ah Kim South Korea	13	278 1.1×	125 1.1×	253 3.2×	78 1.2×	60 0.9×	30	620
Krystyna Widecka Poland	13	98 0.4×	69 0.6×	62 0.8×	92 1.4×	77 1.2×	62	480
Sudhaa Sharma India	14	156 0.6×	42 0.4×	43 0.5×	56 0.8×	56 0.9×	32	508
Jelena Stevanović Netherlands	12	42 0.2×	101 0.9×	39 0.5×	89 1.3×	94 1.5×	39	429
Sri Prakash Mokshagundam United States	13	288 1.2×	135 1.2×	128 1.6×	65 1.0×	126 2.0×	28	597
Alan Sacerdote United States	10	190 0.8×	74 0.7×	55 0.7×	62 0.9×	31 0.5×	24	423
Vijay Shivaswamy United States	14	292 1.2×	88 0.8×	257 3.3×	49 0.7×	58 0.9×	27	586

Countries citing papers authored by R. Townsend

Since Specialization

Citations

This map shows the geographic impact of R. Townsend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Townsend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Townsend more than expected).

Fields of papers citing papers by R. Townsend

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Townsend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Townsend. The network helps show where R. Townsend may publish in the future.

Co-authorship network of co-authors of R. Townsend

This figure shows the co-authorship network connecting the top 25 collaborators of R. Townsend. A scholar is included among the top collaborators of R. Townsend based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Townsend. R. Townsend is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gregory, Sarah, Alex Griffiths, Amy Jennings, et al.. (2024). Adherence to the Eatwell Guide and cardiometabolic, cognitive and neuroimaging parameters: an analysis from the PREVENT dementia study. Nutrition & Metabolism. 21(1). 21–21. 3 indexed citations

Griffiths, Alex, Jamie Matu, Eugene Tang, et al.. (2024). Foods, dietary patterns, and risk of vascular dementia: a systematic review. Nutrition & Metabolism. 21(1). 105–105. 5 indexed citations

Toledo, Manuel, et al.. (2017). Long-term retention rates for antiepileptic drugs: A review of long-term extension studies and comparison with brivaracetam. Epilepsy Research. 138. 53–61. 28 indexed citations

Brandt, Christian, et al.. (2017). Health-related quality of life in double-blind Phase III studies of brivaracetam as adjunctive therapy of focal seizures: A pooled, post-hoc analysis. Epilepsy & Behavior. 69. 80–85. 8 indexed citations

Townsend, R., Kirsty J. Elliott‐Sale, Kevin Currell, et al.. (2017). The Effect of Postexercise Carbohydrate and Protein Ingestion on Bone Metabolism. Medicine & Science in Sports & Exercise. 49(6). 1209–1218. 36 indexed citations

Charokopou, M., et al.. (2016). Applying The Accepted Techniques of Indirect Treatment Comparison to Meet Payer Needs For Brivaracetam Versus Adjunctive Antiepileptic Medications for The Treatment of Focal Seizures In Adult Patients. Do they reflect the need for individualised patient care in heterogeneous populations in epilepsy?. Value in Health. 19(7). A359–A359. 1 indexed citations

Townsend, R., Kirsty J. Elliott‐Sale, Ana Jéssica Pinto, et al.. (2016). Parathyroid Hormone Secretion Is Controlled by Both Ionized Calcium and Phosphate During Exercise and Recovery in Men. The Journal of Clinical Endocrinology & Metabolism. 101(8). 3231–3239. 33 indexed citations

Mumphrey, Michael B., R. Townsend, Laurel M. Patterson, et al.. (2016). Eating in mice with gastric bypass surgery causes exaggerated activation of brainstem anorexia circuit. International Journal of Obesity. 40(6). 921–928. 34 indexed citations

Borghs, Simon, et al.. (2016). Do Accepted Techniques for Indirect Comparative Effectiveness Reflect the need for Individualized Patient Care in Heterogeneous Populations? The Case of Brivaracetam Versus Adjunctive Antiepileptic Medications for the Treatment of Adult Patients with Focal Seizures. Value in Health. 19(3). A71–A71. 1 indexed citations

10.

Charokopou, M., et al.. (2015). Methods applied in cost-effectiveness models for treatment strategies in type 2 diabetes mellitus and their use in Health Technology Assessments: a systematic review of the literature from 2008 to 2013. Current Medical Research and Opinion. 32(2). 207–218. 33 indexed citations

11.

Charokopou, M., Phil McEwan, Steven Lister, et al.. (2015). The cost‐effectiveness of dapagliflozin versus sulfonylurea as an add‐on to metformin in the treatment of Type 2 diabetes mellitus. Diabetic Medicine. 32(7). 890–898. 31 indexed citations

12.

Orme, Michelle, et al.. (2014). A systematic review and mixed-treatment comparison of dapagliflozin with existing anti-diabetes treatments for those with type 2 diabetes mellitus inadequately controlled by sulfonylurea monotherapy. Diabetology & Metabolic Syndrome. 6(1). 73–73. 18 indexed citations

13.

Charokopou, M., et al.. (2013). Overview of Health Economic Models in Type 2 Diabetes Mellitus (T2DM); A Systematic Literature Review. Value in Health. 16(7). A591–A591. 2 indexed citations

14.

Bergenheim, Klas, et al.. (2013). Cost-Effectiveness of Dapagliflozin as Add-On to Insulin for the Treatment of Type 2 Diabetes in the Netherlands. Value in Health. 16(7). A441–A441. 1 indexed citations

15.

Mohamed, Ateesha F., et al.. (2013). Avoidance of weight gain is important for oral type 2 diabetes treatments in Sweden and Germany: Patient preferences. Diabetes & Metabolism. 39(5). 397–403. 33 indexed citations

16.

Bergenheim, Klas, et al.. (2013). Cost Effectiveness of Adding Dapagliflozin to Insulin for the Treatment of Type 2 Diabetes Mellitus in the Netherlands. Clinical Drug Investigation. 34(2). 135–146. 40 indexed citations

17.

Goring, Sarah, Neil Hawkins, Gail Wygant, et al.. (2013). Dapagliflozin compared with other oral anti‐diabetes treatments when added to metformin monotherapy: a systematic review and network meta‐analysis. Diabetes Obesity and Metabolism. 16(5). 433–442. 78 indexed citations

18.

Townsend, R., Phil McEwan, W. Ray Kim, & Yong Yuan. (2011). Structural Frameworks and Key Model Parameters in Cost-Effectiveness Analyses for Current and Future Treatments of Chronic Hepatitis C. Value in Health. 14(8). 1068–1077. 49 indexed citations

19.

Bergenheim, Klas, et al.. (2010). PDB44 THE COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS SULFONYLUREA (SU) IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN GERMANY. Value in Health. 13(7). A291–A292. 1 indexed citations

20.

Kolasa, Katarzyna, et al.. (2010). PDB37 THE COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS NPH INSULIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN POLAND. Value in Health. 13(7). A290–A290. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact